Literature DB >> 30653992

Identification of a Helical Segment within the Intrinsically Disordered Region of the PCSK9 Prodomain.

M Ultsch1, W Li2, C Eigenbrot1, P Di Lello1, M T Lipari2, S Gerhardy2, A P AhYoung2, J Quinn3, Y Franke4, Y Chen5, M Kong Beltran6, A Peterson6, D Kirchhofer7.   

Abstract

Proprotein convertase subtilisin/kexin 9 (PCSK9) is a key regulator of lipid metabolism by degrading liver LDL receptors. Structural studies have provided molecular details of PCSK9 function. However, the N-terminal acidic stretch of the PCSK9 prodomain (Q31-T60) has eluded structural investigation, since it is in a disordered state. The interest in this region is intensified by the presence of human missense mutations associated with low and high LDL-c levels (E32K, D35Y, and R46L, respectively), as well as two posttranslationally modified sites, sulfated Y38 and phosphorylated S47. Herein we show that a segment within this region undergoes disorder-to-order transition. Experiments with acidic stretch-derived peptides demonstrated that the folding is centered at the segment Y38-L45, which adopts an α-helix as determined by NMR analysis of free peptides and by X-ray crystallography of peptides in complex with antibody 6E2 (Ab6E2). In the Fab6E2-peptide complexes, the structured region features a central 2 1/4-turn α-helix and encompasses up to 2/3 of the length of the acidic stretch, including the missense mutations and posttranslationally modified sites. Experiments with helix-breaking proline substitutions in peptides and in PCSK9 protein indicated that Ab6E2 specifically recognizes the helical conformation of the acidic stretch. Therefore, the observed quantitative binding of Ab6E2 to native PCSK9 from various cell lines suggests that the disorder-to-order transition is a true feature of PCSK9 and not limited to peptides. Because the helix provides a constrained spatial orientation of the missense mutations and the posttranslationally modified residues, it is probable that their biological functions take place in the context of an ordered conformational state.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  LDL receptor; intrinsically disordered regions; molecular recognition motif; posttranslational modifications; proprotein convertase

Mesh:

Substances:

Year:  2019        PMID: 30653992     DOI: 10.1016/j.jmb.2018.11.025

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  3 in total

1.  Ser-Phosphorylation of PCSK9 (Proprotein Convertase Subtilisin-Kexin 9) by Fam20C (Family With Sequence Similarity 20, Member C) Kinase Enhances Its Ability to Degrade the LDLR (Low-Density Lipoprotein Receptor).

Authors:  Ali Ben Djoudi Ouadda; Marie-Soleil Gauthier; Delia Susan-Resiga; Emmanuelle Girard; Rachid Essalmani; Miles Black; Jadwiga Marcinkiewicz; Diane Forget; Josée Hamelin; Alexandra Evagelidis; Kevin Ly; Robert Day; Luc Galarneau; Francois Corbin; Benoit Coulombe; Artuela Çaku; Vincent S Tagliabracci; Nabil G Seidah
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-09-05       Impact factor: 8.311

2.  Pathogenic gain-of-function mutations in the prodomain and C-terminal domain of PCSK9 inhibit LDL binding.

Authors:  Samantha K Sarkar; Angela Matyas; Ikhuosho Asikhia; Zhenkun Hu; Mia Golder; Kaitlyn Beehler; Tanja Kosenko; Thomas A Lagace
Journal:  Front Physiol       Date:  2022-09-14       Impact factor: 4.755

3.  A transient amphipathic helix in the prodomain of PCSK9 facilitates binding to low-density lipoprotein particles.

Authors:  Samantha K Sarkar; Alexander C Y Foo; Angela Matyas; Ikhuosho Asikhia; Tanja Kosenko; Natalie K Goto; Ariela Vergara-Jaque; Thomas A Lagace
Journal:  J Biol Chem       Date:  2020-01-16       Impact factor: 5.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.